ZINNAT 250 mg, powder for solution for injection (i.m., I.V.) bottle
Active ingredients: Cefuroxime, Cefuroxime sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injectionbottleintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZINNAT 250 mg, poudre pour solution injectable (I.M., I.V.)
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 22 Aug 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68943502CIP73500878CIP133400935008787Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFUROXIME SODIQUEpoudre | 263 mg · un flacon de poudre | SA |
| CÉFUROXIMEpoudre | 250 mg · un flacon de poudre | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.